The new patent covers Neurosense's formulation of PrimeC, a fixed-dose combo of an approved antibiotic and anti-inflammatory.

ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...

Living well with ALS means we must be mindful, writes columnist Dagmar Munn, who shares an anecdote about an unplanned long walk.

The Mayo Clinic was awarded $12 million to support a study that will give ALS patients access to the investigational therapy ...

A $500,000 MDA research grant to a Mass General investigator will support the HEALEY ALS platform trial that's testing ...

Columnist Juliet Taylor chats with Roon CEO and co-founder Vikram Bhaskaran about this new ALS app designed for patients and ...

Clene will have an in-person meeting with the FDA before the end of November to discuss a potential CNM-Au8 accelerated ...

Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...

A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...

Columnist Juliet Taylor reflects on how the power of music helped her and her late husband, Jeff, navigate the difficulties ...

A man with ALS became the first person to control an Amazon Alexa with his thoughts via an implanted brain-computer interface ...

Amprion was awarded a $100,000 research grant to support studies on the causes of sporadic ALS that could improve diagnosis ...